SRPT · Sarepta Therapeutics, Inc.
Market Cap
$2.33B
Shares
105.63M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| 8-K | 2026-07-27 | 2026-07-23 | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| 8-K | 2026-06-04 | — | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-04-24 | 2026-06-04 | |
| Investor Event Transcript | 2026-03-03 | 2026-03-31 | |
| 10-K | 2026-03-02 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-01-12 | — | |
| Investor Event Transcript | 2026-01-12 | 2026-03-31 | |
| 8-K | 2025-12-19 | 2025-12-18 | |
| 8-K | 2025-12-11 | 2025-12-10 | |
| 8-K | 2025-12-08 | 2025-12-07 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-08-29 | 2025-08-28 | |
| 8-K | 2025-08-21 | 2025-08-18 | |
| 8-K | 2025-08-13 | 2025-08-12 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-07-21 | — | |
| 8-K | 2025-07-16 | 2025-07-14 | |
| 8-K | 2025-06-06 | 2025-06-05 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| DEF 14A | 2025-04-24 | 2025-06-05 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-02-14 | 2025-02-13 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-26 | 2024-11-24 | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-09-16 | 2024-09-12 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 10-Q | 2024-05-01 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | 2024-06-06 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-01-08 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 | |
| 10-Q | 2023-08-02 | 2023-06-30 | |
| 8-K | 2023-06-22 | — | |
| 8-K | 2023-06-22 | — | |
| 8-K | 2023-06-09 | 2023-06-08 | |
| 10-Q | 2023-05-02 | 2023-03-31 | |
| DEF 14A | 2023-04-24 | 0001-01-01 | |
| 8-K | 2023-03-03 | 2023-03-02 | |
| 10-K | 2023-02-28 | 2022-12-31 |
Showing 1–50 of 93 filings
Key facts
CIK
873303
CUSIP
803607100
13F (30d)
287 filings
263 filers
Visit website
Investor relations